|
Ref: PXL/H.O./CIR-045/2016-17 Date: 10.08.2016
Hyderabad
To,
All the Members of Council,
Dear Sir / Madam,
Subject : Interactive Meeting with Shri Sudhanshu Pandey, IAS, Joint Secretary, Department of Commerce on "Free Trade Agreements (FTA) /Regional Comprehensive Economic Partnership (RCEP) " 27th August 2016 at Hotel "The Leela" Mumbai
Meeting Highlights:
-
Trade negotiations with 16 Asian Countries.
-
A rare opportunity for Industry to protect their products against low priced imports and promote their strong products for exports.
Our members are aware of the fact that the bilateral and regional trade agreements are increasingly becoming important in determining the way international trade is happening. Free Trade Agreements (FTAs) between the countries are very important as they facilitate easy and fair & free conduction of trade between the countries. Members may be aware of the initiatives taken by the Government of India in entering into Free Trade Agreements (FTAs) involving several concessions allowed by individual countries towards imports and exports of various commodities depending upon the strengths of individual country.
Some of such trade agreements concluded by India include (a) India - ASEAN Free Trade Agreement (IAFTA), (b) India - Malaysia Comprehensive Economic Cooperation Agreement (IMCECA), (c) India - Korea Comprehensive Economic Partnership Agreement (IKCEPA) among others. India is currently vigorously negotiating for early finalization of Regional Comprehensive Economic Partnership (RCEP) with 10(ten) countries of ASEAN Plus Australia, China, Japan, South Korea and New Zealand. Several rounds of discussion have already taken place amongst the governments of these Countries.
In view of the importance of these Free Trade Agreements (FTAs) and Regional Comprehensive Economic Partnership (RCEP), Department of Commerce, Government of India proposes to engage the Pharma Industry to provide wide market access opportunities to bring down the costs of inputs and the production costs to increase its competitiveness in these markets.
We have pleasure in informing our members that Shri Sudhanshu Pandey, IAS, Joint Secretary, Department of Commerce, Government of India has kindly consented to Chair the interactive meeting and interact with the industry, as per the following schedule:
Day & Date : Saturday, 27th August 2016
Time : 14.00 hours to 16:30 hours (followed by Hi-Tea)
Venue : "The Leela", Sahar, Andheri (E), Mumbai - 400 059
In view of the significance of the interactive meeting and the importance of the challenges faced by the Industry, we would request member companies to nominate their Senior Executives to attend the meeting. Participation is free - there will NOT be any registration charges / fees. However, pre-registration for the meeting is necessary.
We are also pleased to inform our members that Pharmexcil, supported by the Department of Commerce, Government of India has sponsored a comprehensive study on "Increasing Pharma Exports & competitiveness through Free Trade Agreement". A draft report is being prepared and the same is likely to be placed before the members during the interactive meeting and inputs received during the proposed interactive meeting will also be included in the final study report.
Members interested are requested to send your confirmation / your nominee's participation to romumbai@pharmexcil.com with a copy marked to ed@pharmexcil.com and dg@pharmexcil.com at the earliest.
We look forward to full support & cooperation from the Industry for fruitful discussions & increasing India's Pharma exports through FTAs & RCEP.
With regards
Dr. P V Appaji
Director General
|
